In person
Our team will participate in Discovery on Target, the industry’s preeminent event on novel drug targets and technologies for drug discovery professionals. The conference will highlight advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents, ranging from biologics to small molecules.
On Tuesday September 25th ZoBio CEO, Gregg Siegal will present the lecture: ‘The Art of Crafting a Mode of Action: Site Selective Hit Discovery”.
During the entire conference the ZoBio team will be present at booth #325 ready to answer all the questions you may have about our capabilities.
Looking forward to see you in Boston!